(Q36865616)

English

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning

scientific article published on February 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

follicular lymphoma

1 reference

based on heuristic

inferred from title

Robert Peter Gale

4

object named as

Robert Peter Gale

1 reference

Europe PubMed Central

16 August 2017

PMC publication ID

Hillard M. Lazarus

19

object named as

Hillard M Lazarus

1 reference

Europe PubMed Central

16 August 2017

PMC publication ID

18

object named as

Julie M Vose

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

16

object named as

Harry C Schouten

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Koen van Besien

20

object named as

Koen van Besien

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

11

object named as

Gregory A Hale

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

David J. Inwards-Breland

12

object named as

David J Inwards

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Brian J Bolwell

5

object named as

Brian J Bolwell

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

17

object named as

Shimon Slavin

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Parameswaran Hari

1

object named as

Parameswaran Hari

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Jeanette Carreras

2

object named as

Jeanette Carreras

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Christopher N Bredeson

6

object named as

Christopher N Bredeson

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Mitchell S Cairo

8

object named as

Mitchell S Cairo

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Dipnarine Maharaj

14

object named as

Dipnarine Maharaj

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

9

object named as

César O Freytes

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Charles LeMaistre

13

object named as

Charles F Lemaistre

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

author name string

Mei-Jie Zhang

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Linda J Burns

7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Steven C Goldstein

10

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

David I Marks

15

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

publication date

1 February 2008

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

14

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

236-245

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2531158

29 September 2017

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2531158

29 September 2017

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2531158

29 September 2017

Non-myeloablative transplants for malignant disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2531158

29 September 2017

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2531158

29 September 2017

Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2531158

4 September 2018

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2531158

4 September 2018

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2531158

4 September 2018

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2531158

4 September 2018

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2531158

4 September 2018

Nonmyeloablative stem cell transplantation for lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2531158

4 September 2018

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2531158

4 September 2018

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2531158

4 September 2018

Quantification of the completeness of follow-up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2531158

4 September 2018

Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2531158

4 September 2018

Confidence bands for the difference of two survival curves under proportional hazards model

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autogenous recovery of marrow function. Recovery after general exposure to 1082 roentgens of Co60 radiation at 36 roentgens per hour

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic bone marrow transplantation for low-grade lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenous stem cell repopulation resulting in mixed hematopoietic chimerism following total body irradiation and marrow transplantation for acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18215784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2007.11.004

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

release_sktvtbotkncmbnxhkq5uwpy4ee

1 reference

https://api.fatcat.wiki/v0/release/sktvtbotkncmbnxhkq5uwpy4ee

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36865616&oldid=2087844422"